脑心通胶囊临床应用中国专家共识（） - Suppr

Suppr

超能文献

Chinese Experts Consensus on Clinical Application of Naoxintong Capsule ().

作者信息

Long-Tao Liu

机构信息

Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.

出版信息

Chin J Integr Med. 2018 Mar;24(3):232-236. doi: 10.1007/s11655-018-2981-6. Epub 2018 Apr 14.

DOI:10.1007/s11655-018-2981-6

PMID:29654483

Abstract

摘要

相似文献

Chinese Experts Consensus on Clinical Application of Naoxintong Capsule ().脑心通胶囊临床应用中国专家共识（）

Chin J Integr Med. 2018 Mar;24(3):232-236. doi: 10.1007/s11655-018-2981-6. Epub 2018 Apr 14.

[Experts consensus statement on Qilong Capsules in clinical practice].《芪龙胶囊临床应用专家共识声明》

Zhongguo Zhong Yao Za Zhi. 2019 Dec;44(24):5287-5290. doi: 10.19540/j.cnki.cjcmm.20191105.503.

[Clinical study on naoxintong capsule for stroke recovery of Qi-deficiency and blood-stasis syndrome].脑心通胶囊治疗气虚血瘀证中风恢复期的临床研究

Zhongguo Zhong Yao Za Zhi. 2011 Jun;36(11):1530-3.

[Expert consensus for Jiegu Qili Tablets (Capsules) in treatment of fracture in clinical practice].接骨七里片（胶囊）治疗骨折临床应用专家共识

Zhongguo Zhong Yao Za Zhi. 2023 Apr;48(7):1976-1981. doi: 10.19540/j.cnki.cjcmm.20221230.502.

[Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments)].[中药在临床人群中免疫毒性检测的上市后评价专家共识方案（征求意见稿）]

Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(18):2933-6.

[Recommendations on clinical application of Wuling Capsule in psychosomatic related disorders: an expert consensus].《五灵胶囊在心身相关疾病临床应用的专家共识》

Zhonghua Nei Ke Za Zhi. 2020 Jun 1;59(6):427-432. doi: 10.3760/cma.j.cn112138-20191223-00838.

[Expert consensus on clinical application of Compound Congrong Yizhi Capsules in treatment of vascular dementia].《复方苁蓉益智胶囊治疗血管性痴呆临床应用专家共识》

Zhongguo Zhong Yao Za Zhi. 2022 Dec;47(23):6514-6519. doi: 10.19540/j.cnki.cjcmm.20221008.501.

[Study on absorption location of four components from Naoxintong capsule].[脑心通胶囊中四种成分吸收部位的研究]

Zhongguo Zhong Yao Za Zhi. 2013 Mar;38(6):889-93.

Chinese herbal medicine Xinfeng Capsule in treatment of rheumatoid arthritis: study protocol of a multicenter randomized controlled trial.中药新风胶囊治疗类风湿关节炎的多中心随机对照研究方案。

J Integr Med. 2013 Nov;11(6):428-34. doi: 10.3736/jintegrmed2013059.

Comparison of Aspirin and Naoxintong Capsule () with Adjusted-Dose Warfarin in Elderly Patients with High-Risk of Non-Valvular Atrial Fibrillation and Genetic Variants of Vitamin K Epoxide Reductase.阿司匹林与脑心通胶囊（）联合调整剂量华法林用于非瓣膜性房颤高危老年患者及维生素K环氧化物还原酶基因变异的比较

Chin J Integr Med. 2018 Apr;24(4):247-253. doi: 10.1007/s11655-015-2443-4. Epub 2016 Feb 26.

引用本文的文献

Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway.脑心通通过丝裂原活化蛋白激酶（MAPK）途径参与华法林的凝血调节。

Pharmgenomics Pers Med. 2025 Jan 31;18:35-46. doi: 10.2147/PGPM.S489820. eCollection 2025.

Naoxintong capsule for treating cardiovascular and cerebrovascular diseases: from bench to bedside.用于治疗心脑血管疾病的脑心通胶囊：从实验室到临床

Front Pharmacol. 2024 Jun 27;15:1402763. doi: 10.3389/fphar.2024.1402763. eCollection 2024.

Protective effects of paeoniflorin on cardiovascular diseases: A pharmacological and mechanistic overview.芍药苷对心血管疾病的保护作用：药理学与作用机制概述

Front Pharmacol. 2023 May 30;14:1122969. doi: 10.3389/fphar.2023.1122969. eCollection 2023.

Experimental Evidence of Buyang Huanwu Decoction and Related Modern Preparations (Naoxintong Capsule and Yangyin Tongnao Granule) in Treating Cerebral Ischemia: Intestinal Microorganisms and Transcriptomics in Rats.补阳还五汤及相关现代制剂（脑心通胶囊和养血清脑颗粒）治疗脑缺血的实验证据：大鼠肠道微生物与转录组学研究

Evid Based Complement Alternat Med. 2022 Sep 21;2022:4016935. doi: 10.1155/2022/4016935. eCollection 2022.

Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial.补阳还五颗粒与脑心通胶囊治疗稳定性心绞痛的比较：一项随机、双盲、多中心临床试验的原理和设计。

Trials. 2022 Jan 21;23(1):65. doi: 10.1186/s13063-021-05914-1.

Investigation of Invigorating and Activating Blood Circulation Prescriptions in Treating Deficiency and Blood Stasis Syndrome of Ischemic Stroke Patients: Study Protocol for a Randomized Controlled Trial.活血化瘀方剂治疗缺血性中风患者虚瘀证的研究：一项随机对照试验的研究方案

Front Pharmacol. 2020 Jun 17;11:892. doi: 10.3389/fphar.2020.00892. eCollection 2020.

Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats.整合代谢组学和肠道微生物组研究脑心通胶囊对大鼠 2 型糖尿病的作用及机制。

Sci Rep. 2020 Jul 2;10(1):10829. doi: 10.1038/s41598-020-67362-2.

Specific DNA identification of Pheretima in the Naoxintong capsule.脑心通胶囊中地龙的特异性DNA鉴定

Chin Med. 2019 Sep 30;14:41. doi: 10.1186/s13020-019-0264-7. eCollection 2019.

本文引用的文献

Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.脑心通通过抑制NLRP3炎性小体激活减轻缺血/再灌注损伤。

J Cell Mol Med. 2017 Jan;21(1):4-12. doi: 10.1111/jcmm.12915. Epub 2016 Oct 26.

Naoxintong/PPARα Signaling Inhibits H9c2 Cell Apoptosis and Autophagy in Response to Oxidative Stress.脑心通/PPARα信号通路抑制H9c2细胞在氧化应激反应中的凋亡和自噬。

Evid Based Complement Alternat Med. 2016;2016:4370381. doi: 10.1155/2016/4370381. Epub 2016 Sep 7.

Up-Regulation of CYP2C19 Expression by BuChang NaoXinTong via PXR Activation in HepG2 Cells.步长脑心通通过激活PXR上调HepG2细胞中CYP2C19的表达

PLoS One. 2016 Jul 28;11(7):e0160285. doi: 10.1371/journal.pone.0160285. eCollection 2016.

Protective effect of Naoxintong against cerebral ischemia reperfusion injury in mice.脑心通对小鼠脑缺血再灌注损伤的保护作用

J Ethnopharmacol. 2016 Apr 22;182:181-9. doi: 10.1016/j.jep.2016.02.022. Epub 2016 Feb 20.

Metabolomics study on the effects of Buchang Naoxintong capsules for treating cerebral ischemia in rats using UPLC-Q/TOF-MS.基于超高效液相色谱-四极杆/飞行时间质谱联用技术的步长脑心通胶囊对大鼠脑缺血治疗作用的代谢组学研究

J Ethnopharmacol. 2016 Mar 2;180:1-11. doi: 10.1016/j.jep.2016.01.016. Epub 2016 Jan 19.

NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.脑心通抑制载脂蛋白E缺乏小鼠的晚期动脉粥样硬化并增强斑块稳定性。

J Cardiovasc Pharmacol. 2016 Mar;67(3):203-11. doi: 10.1097/FJC.0000000000000334.

A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism.一项针对携带CYP2C19*2基因多态性患者的随机对照试验：辅助使用步长脑心通胶囊与维持剂量氯吡格雷的对比研究

Chin J Integr Med. 2014 Dec;20(12):894-902. doi: 10.1007/s11655-014-2023-z. Epub 2014 Nov 27.

In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong.醒脑通的体外细胞色素 P450 2C19 潜在活性评估。

Evid Based Complement Alternat Med. 2012;2012:430262. doi: 10.1155/2012/430262. Epub 2012 Feb 16.

Efficacy of dual antiplatelet therapy combined with Naoxintong capsules [see text] following coronary microembolization induced by homologous microthrombi in rats.同源微血栓致大鼠冠状动脉微栓塞后双联抗血小板治疗联合脑心通胶囊的疗效[见正文]。

Chin J Integr Med. 2011 Dec;17(12):917-24. doi: 10.1007/s11655-011-0935-4. Epub 2011 Dec 3.

Comparison of Adjunctive Naoxintong versus Clopidogrel in Volunteers with the CYP2C19*2 Gene Mutation Accompanied with Qi Deficiency and Blood Stasis Constitution.伴有气虚血瘀证 CYP2C19*2 基因变异的志愿者中，加用脑心通与氯吡格雷的疗效比较。

Evid Based Complement Alternat Med. 2011;2011:207034. doi: 10.1155/2011/207034. Epub 2011 Mar 1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验